CG
ORTX

Cutler Group’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Cutler Group’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-110
Closed -$3K – 6485
2020
Q4 		$3K Buy
+110
New +$4.93K ﹤0.01% 4054

Other funds holding ORTX

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Cutler Group's ORTX Position: Q4 2021 in Review

Cutler Group sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2021, closing a stake of 20 shares.

Cutler Group first reported a position in ORTX in Q4 2020 and held it in 3 quarters. The position peaked at $6K in Q4 2020. 72 funds tracked by Wall St. Rank hold ORTX as of Q4 2021.

  • Cutler Group reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • Cutler Group sold 20 Orchard Therapeutics plc American Depositary Shares shares in Q4 2021.
  • Cutler Group first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2020 and held it in 3 quarters.
  • Cutler Group's Orchard Therapeutics plc American Depositary Shares position peaked at $6K in Q4 2020.
  • 72 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2021.

Based on Cutler Group's 13F filing for Q4 2021, filed 18 Jan 2022.